Future work could explore in depth the functional role of the PTPN11 phosphorylated residues (Y62, Y542 and Y580) in signalling activation, drug resistance and cancer immunity in the EML4-ALK + NSCLC. The gene discussed is PTPN11; the disease is non-small cell lung carcinoma.